Investment Summary

Eight Roads Invests In Chai Point

On September 16, 2015, private equity firm Eight Roads invested in beverage company Chai Point

Investment Highlights
  • This is Eight Roads’ 1st transaction in the Beverages sector.
  • This is Eight Roads’ 19th transaction in India.

Investment Summary

Date 2015-09-16
Target Chai Point
Sector Beverages
Investor(s) Eight Roads
Deal Type Venture

Target

Chai Point

Bangalore, India
Chai Point is a tea retail chain with physical stores and online chai delivery services. Chai Point was founded in 2010 and is based in Bangalore, Karnataka.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Eight Roads

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


DEAL STATS #
Overall 111 of 293
Sector: Beverages M&A 1 of 1
Type: Venture M&A Deals 93 of 266
Country: India M&A 19 of 37
Year: 2015 M&A 23 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-16 Regenxbio

Rockville, Maryland, United States

Regenxbio is a clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Regenxbio’s NAV® Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. Regenxbio and its third-party NAV Technology licensees are applying the NAV Technology Platform in the development of a broad pipeline of product candidates in multiple therapeutic areas. Regenxbio was founded in 2008 and is based in Rockville, Maryland.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-29 more2

London, United Kingdom

more2 is a data analytics and marketing platform that provides strategy, segmentation and modeling, reporting and analysis, technology, and campaign services to grow retail businesses in the United Kingdom and internationally. It serves fashion, fitness, food and drink, health and beauty, lifestyle, outdoor, and technology clients. more2 was founded in 2002 and is based in London, United Kingdom.

Buy -